NNOX nanox.vision: מכפיל P/S עתידי

Nano-X Imaging Ltd. is breaking through in diagnostics by creating digital X-ray systems featuring cold cathode technology and AI analytics. The forward P/S trend clearly demonstrates market expectations, where the 1.60 mark captures this metric. The model relies on contract manufacturing and cloud services, while business protection is based on patents and FDA certifications.

For Nano-X Imaging Ltd. (NNOX), whose market niche protection is based on cold cathode patents and FDA approvals, this indicator assesses capitalization relative to projected sales volume. By analyzing the forward price-to-sales ratio, an investor determines whether the current premium for technological leadership is justified and evaluates the risk of overpayment prior to the full commercial deployment of systems across the global clinic network.